Ngā hua rapu - Nicola, Mozzillo
- E whakaatu ana i te 1 - 20 hua o te 26
- Haere ki te Whārangi Whai Ake
-
1
-
2
Sequencing of BRAF inhibitors and ipilimumab in patients with metastatic melanoma: a possible algorithm for clinical use mā Paolo A. Ascierto, Ester Simeone, Diana Giannarelli, Antonio M. Grimaldi, Anna Virgínia Calazans Romano, Nicola Mozzillo
I whakaputaina 2012Artigo -
3
-
4
Long-lasting response to electrochemotherapy in melanoma patients with cutaneous metastasis mā Corrado Caracò, Nicola Mozzillo, Ugo Marone, Ester Simeone, Lucia Benedetto, Gianluca Di Monta, Maria Luisa Di Cecilia, Gerardo Botti, Paolo A. Ascierto
I whakaputaina 2013Artigo -
5
-
6
The role of BRAF V600 mutation in melanoma mā Paolo A. Ascierto, John M. Kirkwood, Jean‐Jacques Grob, Ester Simeone, Antonio M. Grimaldi, Michele Maio, Giuseppe Palmieri, Alessandro Testori, Francesco M. Marincola, Nicola Mozzillo
I whakaputaina 2012Editorial -
7
Correlation between immune-related adverse events and response to pembrolizumab in advanced melanoma patients mā Antonio M. Grimaldi, Ester Simeone, Lucia Festino, Diana Giannarelli, Marco Palla, Corrado Caracò, Marcello Curvietto, Assunta Esposito, Maria Grazia Grimaldi, Nicola Mozzillo, Paolo A. Ascierto
I whakaputaina 2015Artigo -
8
Electrochemotherapy efficacy evaluation for treatment of locally advanced stage III cutaneous squamous cell carcinoma: a 22-cases retrospective analysis mā Gianluca Di Monta, Corrado Caracò, Ester Simeone, Antonio M. Grimaldi, Ugo Marone, Massimiliano Di Marzo, Vito Vanella, Lucia Festino, Marco Palla, Stefano Mori, Nicola Mozzillo, Paolo A. Ascierto
I whakaputaina 2017Artigo -
9
AurkA inhibitors enhance the effects of B-RAF and MEK inhibitors in melanoma treatment mā Emilia Caputo, Roberta Miceli, Maria Letizia Motti, Rosarita Tatè, Federica Fratangelo, Gerardo Botti, Nicola Mozzillo, Maria Vincenza Carriero, Ernesta Cavalcanti, Giuseppe Palmieri, Gennaro Ciliberto, Giuseppe Pirozzi, Paolo A. Ascierto
I whakaputaina 2014Artigo -
10
Assessment of Prognostic Circulating Tumor Cells in a Phase III Trial of Adjuvant Immunotherapy After Complete Resection of Stage IV Melanoma mā Sojun Hoshimoto, Mark B. Faries, Donald L. Morton, Tatsushi Shingai, Christine Kuo, He Jing Wang, Robert M. Elashoff, Nicola Mozzillo, Mark C. Kelley, John F. Thompson, Jeffrey E. Lee, Dave S.�B. Hoon
I whakaputaina 2011Artigo -
11
Nonsentinel Lymph Node Status in Patients With Cutaneous Melanoma: Results From a Multi-Institution Prognostic Study mā Sandro Pasquali, Simone Mocellin, Nicola Mozzillo, Andrea Maurichi, Pietro Quaglino, Lorenzo Borgognoni, Nicola Solari, Dario Piazzalunga, L. Mascheroni, Giuseppe Giudice, Roberto Patuzzo, Corrado Caracò, Simone Ribero, Ugo Marone, Mario Santinami, Carlo Riccardo Rossi
I whakaputaina 2014Artigo -
12
Validation of the Accuracy of Intraoperative Lymphatic Mapping and Sentinel Lymphadenectomy for Early-Stage Melanoma mā Donald L. Morton, John F. Thompson, Richard Essner, Robert M. Elashoff, Stacey L. Stern, Omgo E. Nieweg, Daniel F. Roses, Constantine P. Karakousis, Nicola Mozzillo, Douglas S. Reintgen, He-Jing Wang, M Edwin, Carolyn Glass, Alistair J. Cochran
I whakaputaina 1999Artigo -
13
Abscopal effects of radiotherapy on advanced melanoma patients who progressed after ipilimumab immunotherapy mā Antonio M. Grimaldi, Ester Simeone, Diana Giannarelli, Paolo Muto, Sara Falivene, Valentina Borzillo, F Giugliano, Fabio Sandomenico, Antonella Petrillo, Marcello Curvietto, Assunta Esposito, Miriam Paone, Marco Palla, Giuseppe Palmieri, Corrado Caracò, Gennaro Ciliberto, Nicola Mozzillo, Paolo A. Ascierto
I whakaputaina 2014Artigo -
14
Sentinel Node Biopsy for Early-Stage Melanoma mā Donald L. Morton, Alistair J. Cochran, John F. Thompson, Robert M. Elashoff, Richard Essner, Edwin C. Glass, Nicola Mozzillo, Omgo E. Nieweg, Daniel F. Roses, Harald J. Hoekstra, Constantine P. Karakousis, Douglas S. Reintgen, Brendon J. Coventry, Hong Wang
I whakaputaina 2005Artigo -
15
Treatment efficacy with electrochemotherapy: A multi-institutional prospective observational study on 376 patients with superficial tumors mā L Campana, Alessandro Testori, Paolo Curatolo, Pietro Quaglino, Simone Mocellin, Massimo Framarini, Lorenzo Borgognoni, Paolo A. Ascierto, Nicola Mozzillo, Michele Guida, S. Bucher, Roberta Rotunno, Federica Marenco, Gian Luca De Salvo, Angela De Paoli, Carlo Riccardo Rossi, A Bonadies
I whakaputaina 2016Artigo -
16
Sentinel-Node Biopsy or Nodal Observation in Melanoma mā Donald L. Morton, John F. Thompson, Alistair J. Cochran, Nicola Mozzillo, Robert M. Elashoff, Richard Essner, Omgo E. Nieweg, Daniel F. Roses, Harald J. Hoekstra, Constantine P. Karakousis, Douglas S. Reintgen, Brendon J. Coventry, Edwin C. Glass, He-Jing Wang
I whakaputaina 2006Artigo -
17
Assessing a novel immuno-oncology-based combination therapy: Ipilimumab plus electrochemotherapy mā Nicola Mozzillo, Ester Simeone, Lucia Benedetto, Marcello Curvietto, Diana Giannarelli, Giusy Gentilcore, Rosa Camerlingo, Mariaelena Capone, Gabriele Madonna, Lucia Festino, Corrado Caracò, Gianluca Di Monta, Ugo Marone, Massimiliano Di Marzo, Antonio M. Grimaldi, Stefano Mori, Gennaro Ciliberto, Paolo A. Ascierto
I whakaputaina 2015Artigo -
18
The Impact on Morbidity and Length of Stay of Early Versus Delayed Complete Lymphadenectomy in Melanoma: Results of the Multicenter Selective Lymphadenectomy Trial (I) mā Mark B. Faries, John F. Thompson, Alistair J. Cochran, Robert M. Elashoff, Edwin C. Glass, Nicola Mozzillo, Omgo E. Nieweg, Daniel F. Roses, H.J. Hoekstra, Constantine P. Karakousis, Douglas S. Reintgen, Brendon J. Coventry, He-Jing Wang, Donald L. Morton
I whakaputaina 2010Artigo -
19
<i>BRAF/NRAS</i> Mutation Frequencies Among Primary Tumors and Metastases in Patients With Melanoma mā Maria Colombino, Mariaelena Capone, Amelia Lissia, Antonio Cossu, Corrado Rubino, Vincenzo De Giorgi, Daniela Massi, Ester Fonsatti, Stefania Staibano, Oscar Nappi, Elena Pagani, Milena Casula, Antonella Manca, Maria Cristina Sini, Renato Franco, Gerardo Botti, Corrado Caracò, Nicola Mozzillo, Paolo A. Ascierto, Giuseppe Palmieri
I whakaputaina 2012Artigo -
20
Immunological and biological changes during ipilimumab treatment and their potential correlation with clinical response and survival in patients with advanced melanoma mā Ester Simeone, Giusy Gentilcore, Diana Giannarelli, Antonio M. Grimaldi, Corrado Caracò, Marcello Curvietto, Assunta Esposito, Miriam Paone, Marco Palla, Ernesta Cavalcanti, Fabio Sandomenico, Antonella Petrillo, Gerardo Botti, Franco Fulciniti, Giuseppe Palmieri, Paola Queirolo, Paolo Marchetti, Virginia Ferraresi, Gaetana Rinaldi, Maria Pia Pistillo, Gennaro Ciliberto, Nicola Mozzillo, Paolo A. Ascierto
I whakaputaina 2014Artigo
Ngā utauta rapu:
Ngā marau whai pānga
Medicine
Cancer research
Melanoma
Internal medicine
Cancer
Oncology
Biology
Surgery
Immunotherapy
Ipilimumab
Biochemistry
Breast cancer
Immunology
Lymph node
Lymphadenectomy
MAPK/ERK pathway
Metastatic melanoma
Paleontology
Radiology
Sentinel node
Stage (stratigraphy)
Adverse effect
Biopsy
Bleomycin
Cell biology
Chemotherapy
Clinical trial
Confidence interval
Electrochemotherapy
Gene